Congratulations to our CaRE2 leader, Dr. John Allen, on a major publication in Clinical Pharmacology & Therapeutics. Great work!
Title: Evaluation of potential racial disparities in CYP2C19-Guided P2Y12 inhibitor prescribing after percutaneous coronary intervention
Link: http://ow.ly/NwRJ50LwNsf
